Global Needle-Free Diabetes Care Market was valued US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2027, at a CAGR of 7.80 % during a forecast period.
Global Needle-Free Diabetes Care Market
The report study has analyzed the revenue impact of the COVID-19 pandemic on the sales revenue of the market leader, market followers, and market disrupters in the report, and the same is reflected in our analysis.
Diabetes is a chronic disease, which is characterized by elevated levels of blood glucose. It leads to serious damage to the heart, blood vessels, eyes, kidneys, and nerves. Diabetes is the seventh leading cause of death and a major cause of debilitating complications like heart attacks, stroke, kidney failure, and blindness. Needle-free diabetes care refers to treatment, which is used to monitor the glucose of diabetic patients without needles. Needle-free diabetes devices are used for injecting insulin and monitoring blood glucose levels in diabetic patients.
Global Needle-Free Diabetes Care Market, Dynamics:
The growth in the geriatric population, prevalence of diabetes, and the introduction of the some of the technological innovations are some of the prominent factors behind the global needle-free diabetes care market growth. The development of technologically advanced diabetes control devices is becoming necessary to ensure increased healthcare efficiency and productivity. Currently, diabetic patients have needed to prick their fingers to obtain blood samples to monitor glucose level in the body.
An increase in awareness regarding the safety issues associated with needles is expected to drive the market growth. In addition, the development of advanced biosensors, glucose monitoring devices are becoming easy to operate and painless. It can be used at home that helps patients to monitor the glucose level easily. Recently, the treatment of diabetes is becoming needle-free with the development of advanced insulin jet injectors. The innovative devices help patients to painlessly inject drugs themselves.
Despite a sufficient supply, insulin prices are becoming a barrier to treatment in most low- and middle-income countries across the globe. Furthermore, advancements like the artificial pancreas and home infusion therapy are expected to create significant growth opportunities during the forecast period.
Global Needle-Free Diabetes Care Market, Segment Analysis:
Needle-Free diabetes care is a path-breaking technology. Currently, the suitable options available for automating the complicated daily process of blood sugar management are continuous glucose monitors and insulin pumps. The technological advancement and adoption of insulin pumps over traditional methods are expected to drive market growth. The Insulin pumps are expected to grow at a more than 17% rate of CAGR during the forecast period. Insulin pumps are highly convenient for people who necessitate multiple insulin injections on a daily basis.
Global Needle-Free Diabetes Care Market, Regional Analysis:
North America held the leading position in 2019 and it is projected to contribute XX% share in the global needle-free diabetes care market. The maximum share in the market is attributed to the presence of the well-established healthcare infrastructure and growth in the prevalence of obesity. Technological advancements and innovative product launches are expected to drive regional growth. The region is a pioneer in healthcare and has advanced medical facilities. The availability of skilled health professionals and high purchasing power is expected to boost regional market growth.
Global Needle-Free Diabetes Care Market, Competitive Analysis:
Some of the prominent key players are focusing on developing technologies, which is expected to replace the poke with a patch. The manufacturers are focusing on the development of numerous techniques like transdermal patches, which helps to read blood sugar levels through the skin without drawing the blood. The key players in the needle-free diabetes care market are concentrating on workflow enhancements and the development of new generation insulin pumps with advanced technology to provide better compliance and integration with IT devices.
The objective of the report is to present a comprehensive analysis of the Global Needle-Free Diabetes Care Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Needle-Free Diabetes Care Market dynamics, structure by analyzing the market segments and projects the Global Needle-Free Diabetes Care Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Needle-Free Diabetes Care Market make the report investor’s guide.
Scope of the Global Needle-Free Diabetes Care Market
Global Needle-Free Diabetes Care Market, By Type of Device
• Treatment devices
o Insulin patches
o Jet Injectors
o Insulin pens
o Insulin pumps
o Insulin infuser
• Diagnostic devices
o Continuous glucose monitoring
o Instant glucose monitoring
Global Needle-Free Diabetes Care Market, By End User
• Diagnostic Centers
• Hospitals and Clinics
• Consumer
Global Needle-Free Diabetes Care Market, By Region
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America
Key players operating in Global Needle-Free Diabetes Care Market
• 3M
• Glide Pharmaceutical Technologies Ltd
• Pancreum LLC
• Akra Dermojet
• Tandem Diabetes Care, Inc
• Pharmajet, Inc
• Medtronic, Inc.
• European Pharma Group BV
• Antares Pharma, Inc.
• Bioject Medical Technologies Inc
• Injex Pharma Ag
• Medical International Technology, Inc
• National Medical Products Inc
• Penjet Corporation
• Zogenix, Inc.
• Johnson & Johnson
• Echo Therapeutics Inc
• MannKind Corporation
For More Information Visit @: https://www.maximizemarketresearch.com/
This Report Is Submitted By :Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: LumawantGodage
Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: sales@maximizemarketresearch.com
Address:Pune, Maharashtra 411051, India.
Contact: +919607195908
0 Comments